For over 20 years, LABDOM has been at the frontier of research and development of revolutionary technologies for biomolecular therapies in Switzerland & Europe, producing a diverse array of products for international brands. Those years had seen LABDOM extending its technical know-how to help develop some of the world’s most revered functional food, supplements and biomolecular peptide therapies.

After divesting its brands to several new investors early 2015, LABDOM now focuses its resources as a business incubator to help consolidate best practices for global biomolecular and nutritional therapies, and generate the next generation of wellness solutions.